
| Tablets containing Cefpodoxime Proxetil, the most versatile third generation cephalosporin that has a broad spectrum of action. | |
| Potent antibacterial activity against both gram positive and gram negative bacteria. | |
| More stable to beta lactamase producing strain. | |
| It is the drug of choice for respiratory tract infections and has an excellent safety profile. |
Indication |
Dosage |
URTI / LRTI |
100 mg b.d. for 5- 10 days |
Acute exacerbations of chronic bronchitis |
200 mg 12 hourly for 10 days |
Pneumonia |
200 mg 12 hourly for 10 days |
| Acute uncomplicated gonorrhoea | 200mg single dose |
| UTI | 100mg b.d. for 7 days |
| Skin infections | 400mg b.d. for 7 –14 days |
| Acute otitis media | 5mg/ kg 12 hourly (max 400mg/ dose) for 5 days |
| Acute maxillary sinusitis | 5mg/ kg 12 hourly (max 200mg/ dose) for 10 days |
| Pharyngitis and tonsillitis | 5mg/ kg 12 hourly (max 100mg/ dose) for 5 - 10 days |